See every side of every news story
Published loading...Updated

To answer a question Are they all the same

Summary by Multiple Sclerosis Research Blog
Someone of the blog asked if there were head to head studies with rituximab and ocrelizumab and I said besides the real world study of MS Base there were trials in Denmark; Norway; France the Nethe…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Multiple Sclerosis Research Blog broke the news in on Thursday, April 17, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.